The standard of care for eligible patients is typically radical cystectomy, a major surgical procedure involving the complete removal of the bladder, often accompanied by the removal of nearby lymph nodes and other organs in the pelvic region. They are used in various settings, including after surgery to reduce the risk of recurrence (adjuvant therapy) or for treating cancers that have spread (metastatic disease).
Latest Advances in Bladder Cancer Best Treatment Immunotherapy
Following TURBT, the risk of recurrence frequently necessitates adjuvant intravesical therapy, where medication is instilled directly into the bladder to attack any remaining cancer cells and reduce the chance of the cancer returning. Factors beyond the cancer itself play a crucial role in this equation.
A patient's age, pre-existing medical conditions, kidney and bladder function, and personal values regarding quality of life versus quantity of life must all be integrated into the decision-making process. Conversely, an older adult with multiple health issues may opt for a less invasive approach that focuses on managing symptoms and preserving daily function.
Latest Advances in Bladder Cancer Best Treatment Immunotherapy
These medications work by unleashing the patient's own immune system to recognize and attack cancer cells. Targeting Muscle-Invasive Disease When cancer progresses to muscle-invasive bladder cancer (MIBC), meaning it has grown into the muscular layer of the bladder wall, the treatment goals shift toward curing the disease or controlling its spread.
More About Bladder cancer best treatment
Looking at Bladder cancer best treatment from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Bladder cancer best treatment can make the topic easier to follow by connecting earlier points with a few simple takeaways.
